295 related articles for article (PubMed ID: 30334947)
1. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis.
Wallwork R; Wallace Z; Perugino C; Sharma A; Stone JH
Medicine (Baltimore); 2018 Oct; 97(42):e12631. PubMed ID: 30334947
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related retroperitoneal fibrosis: a newly characterized disease.
Lian L; Wang C; Tian JL
Int J Rheum Dis; 2016 Nov; 19(11):1049-1055. PubMed ID: 27125330
[TBL] [Abstract][Full Text] [Related]
3. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.
Khosroshahi A; Carruthers MN; Stone JH; Shinagare S; Sainani N; Hasserjian RP; Deshpande V
Medicine (Baltimore); 2013 Mar; 92(2):82-91. PubMed ID: 23429355
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
Koo BS; Koh YW; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2015 Mar; 25(2):194-8. PubMed ID: 25036229
[TBL] [Abstract][Full Text] [Related]
6. No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.
Forestier A; Buob D; Mirault T; Puech P; Gnemmi V; Launay D; Hachulla E; Hatron PY; Lambert M
Clin Exp Rheumatol; 2018; 36(3):371-375. PubMed ID: 29465374
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G4-related retroperitoneal fibrosis.
Angarola E; Valeo Chulvi M; Peuchot V; García Rivello H; Jauk F
Medicina (B Aires); 2022; 82(1):91-98. PubMed ID: 35037866
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study.
Liu Y; Zhu L; Wang Z; Zeng Q; Yang F; Gao J; Wang Z; Wang K; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li Z
Rheumatology (Oxford); 2021 Feb; 60(2):767-772. PubMed ID: 32793960
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach.
Urban ML; Palmisano A; Nicastro M; Corradi D; Buzio C; Vaglio A
Rev Med Interne; 2015 Jan; 36(1):15-21. PubMed ID: 25455951
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis.
Wang K; Wang Z; Zeng Q; Zhu L; Gao J; Wang Z; Zhang S; Yang F; Shen D; Wang Y; Liu Y
PLoS One; 2021; 16(2):e0245601. PubMed ID: 33600452
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease.
Rossi GM; Rocco R; Accorsi Buttini E; Marvisi C; Vaglio A
Intern Emerg Med; 2017 Apr; 12(3):287-299. PubMed ID: 28070877
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Retroperitoneal Fibrosis Patients at a Tertiary Hospital in Japan.
Ando M; Hanayama Y; Nishimura Y; Hagiya H; Otsuka F
Acta Med Okayama; 2023 Oct; 77(5):527-536. PubMed ID: 37899264
[TBL] [Abstract][Full Text] [Related]
13. Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab.
Adam Z; Čermák A; Petrášová H; Řehák Z; Koukalová R; Fojtík Z; Pour L; Boichuk I; Krejčí M; Král Z; Benda P
Vnitr Lek; 2023; 69(E-3):4-15. PubMed ID: 37468330
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.
Lomborg N; Jakobsen M; Bode CS; Junker P
Scand J Rheumatol; 2019 Jul; 48(4):320-325. PubMed ID: 30931680
[No Abstract] [Full Text] [Related]
15. Idiopathic Retroperitoneal Fibrosis.
Vaglio A; Maritati F
J Am Soc Nephrol; 2016 Jul; 27(7):1880-9. PubMed ID: 26860343
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
Ebbo M; Grados A; Samson M; Groh M; Loundou A; Rigolet A; Terrier B; Guillaud C; Carra-Dallière C; Renou F; Pozdzik A; Labauge P; Palat S; Berthelot JM; Pennaforte JL; Wynckel A; Lebas C; Le Gouellec N; Quémeneur T; Dahan K; Carbonnel F; Leroux G; Perlat A; Mathian A; Cacoub P; Hachulla E; Costedoat-Chalumeau N; Harlé JR; Schleinitz N
PLoS One; 2017; 12(9):e0183844. PubMed ID: 28915275
[TBL] [Abstract][Full Text] [Related]
17. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made?
Cohan RH; Shampain KL; Francis IR; Davenport MS; Stuart Wolf J; Marder W; Swartz RD
Abdom Radiol (NY); 2018 May; 43(5):1204-1214. PubMed ID: 28849414
[TBL] [Abstract][Full Text] [Related]
18. Large vessel involvement by IgG4-related disease.
Perugino CA; Wallace ZS; Meyersohn N; Oliveira G; Stone JR; Stone JH
Medicine (Baltimore); 2016 Jul; 95(28):e3344. PubMed ID: 27428181
[TBL] [Abstract][Full Text] [Related]
19. Chronic Tubulo-interstitial Pyelonephritis with Retroperitoneal Fibrosis.
Soneja M; Achintya S; Nischal N; Ranjan P; Vyas S; Arava S; Sharma SK
J Assoc Physicians India; 2016 Jun; 64(6):71. PubMed ID: 27739273
[TBL] [Abstract][Full Text] [Related]
20. An Interesting Case of Immunoglobulin G4-Related Retroperitoneal Fibrosis Treated With Rituximab.
Hamdan A; Moeen Z; Tariq H; Olson O; Matute-Martinez C; Sidhu M; Mukkera S
Cureus; 2021 Sep; 13(9):e17940. PubMed ID: 34660129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
